Key result
Interlead QRS dispersion of the surface ECG precordial leads successfully differentiated arrhythmogenic right ventricular cardiomyopathy from controls and correlated with the extent of abnormal epicardial substrate.
Why the study?
Does interlead QRS dispersion on surface ECG identify abnormal ventricular substrate and differentiate ARVC from controls?
Observational (n=71)
Does interlead QRS dispersion on surface ECG identify abnormal ventricular substrate and differentiate ARVC from controls?
Interlead QRS dispersion on surface ECG can noninvasively differentiate ARVC from controls and identify abnormal ventricular substrate.
Answers are grounded in this paper and cite their sources.
May support noninvasive ECG identification of ARVC substrate; hypothesis-generating and requires prospective validation before clinical use.
BACKGROUND: This study investigated the feasibility of using the precordial surface ECG lead interlead QRS dispersion (IQRSD) in the identification of abnormal ventricular substrate in arrhythmogenic right ventricular cardiomyopathy (ARVC). METHODS: Seventy-one consecutive patients were enrolled and reclassified into 4 groups: definite ARVC with epicardial ablation (Group 1), ARVC with ventricular tachycardia (VT, Group 2), idiopathic right ventricular outflow tract VT without ARVC (Group 3), and controls without VT (Group 4). IQRSD was quantified by the angular difference between the reconstruction vectors obtained from the QRS-loop decomposition, based on a principal component analysis (PCA). Electroanatomic mapping and simulated ECGs were used to investigate the relationship between QRS dispersion and abnormal substrate. RESULTS: The percentage of the QRS loop area in the Group 1-2 was smaller than the controls (P = 0.01). The IQRSD between V1-V2 could differentiate all VTs from control (P<0.01). Group 1-2 had a greater IQRSD than the Group 3-4 (V4-V5,P = 0.001), and Group 1 had a greater IQRSD than Group 3-4 (V6-Lead I, P<0.001). Both real and simulated data had a positive correlation between the maximal IQRSD (γ = 0.62) and the extent of corresponding abnormal substrate (γ = 0.71, both P<0.001). CONCLUSIONS: The IQRSD of the surface ECG precordial leads successfully differentiated ARVC from controls, and could be used as a noninvasive marker to identify the abnormal substrate and the status of ARVC patients who can benefit from epicardial ablation.
No takes yet. Share an insight, caveat, or question.
Hsieh et al. (2017) conducted an observational in Arrhythmogenic right ventricular cardiomyopathy (ARVC) (n=71). Interlead QRS dispersion (IQRSD) analysis vs. Idiopathic RVOT-VT and controls was evaluated on Interlead QRS dispersion (IQRSD) between V4-V5 differentiating definite ARVC from idiopathic RVOT-VT and controls (p=0.001). Interlead QRS dispersion of the surface ECG precordial leads successfully differentiated arrhythmogenic right ventricular cardiomyopathy from controls and correlated with the extent of abnormal epicardial substrate.
Synapse has enriched 10 related papers. Consider them for comparative context: